Raffo writes that, These combined effects are particularly intriguing for orthopedics because many musculoskeletal injuries (Achilles tendon ruptures, rotator cuff tears, chronic tendinopathies) occur in precisely those areas where blood flow is limited and healing is frustratingly slow. However, to be clear, BPC-157 is not FDA approved
Arthritis Res Ther (2018) 20(1):114
TB-500, by contrast, acts systemically by mobilizing endothelial precursors, regulatory T-cells, and stem cells throughout the body
If the coating failsdue to manufacturing inconsistency, storage humidity, or gastric pH variabilitythe peptide degrades before reaching target tissue
many of these effects were still evident one month after treatment ended
Tucson Wellness MD offers medically supervised peptide therapy consultations